-
Tevimbra Plus Chemo May Be Safe, Effective in Advanced Gastric/GEJ Cancer
05 Feb 2025 01:51 GMT
… Complete response: disappearance of cancer.
Disease control rate: patients … -based chemotherapy in patients with advanced gastric cancer, evidenced … 47;m2 Q2W, and 5-FU at 2400 mg… irinotecan, paclitaxel, oxaliplatin and 5-FU/levoleucovorin) as first …
-
Watch and Wait Post-TNT Safe with Similar Outcomes to TME in Rectal Cancer
31 Jan 2025 18:56 GMT
… , MD, of Memorial Sloan Kettering Cancer Center, stated during the presentation … ], and oxaliplatin) for systemic chemotherapy and 5-fluorouracil (5-FU) plus oxaliplatin CRT at 50 …
-
Dr Raghav on ABBV-400 Plus 5-FU, Folinic Acid, and Bevacizumab in Previously Treated mCRC
31 Jan 2025 23:08 GMT
… in combination with fluorouracil (5-FU), folinic acid, and bevacizumab … previously treated metastatic colorectal cancer (mCRC).
In this … At the 2025 Gastrointestinal Cancers Symposium,Raghav presented the … 400 in combination with chemotherapy at varying dose …
-
The Impact of Nutritional Status and Tumor-Infiltrating Lymphocytes (CD4+ and CD8+) on Chemotherapy Response in Colorectal Cancer Patients
31 Jan 2025 13:38 GMT
… 1.The chemotherapy regimen may include various agents such as 5-Fluorouracil (5-FU), followed … pathogenesis of sporadic colorectal cancers. Chin J Cancer. 2016;35:4. … outcome in advanced colorectal cancer patients receiving chemotherapy with or without …
-
Ginger-Derived Exosome-Like Nanoparticles Loaded With Indocyanine Green Enhances Phototherapy Efficacy for Breast Cancer
30 Jan 2025 07:20 GMT
… recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum … cell and therapeutic implications in cancer. Cancer Lett. 2023;567:216267. … Redox Status and Chemoresistance in Human Angiosarcomas. Clin Cancer Res. 2018; …
-
Pembrolizumab Combo Does Not Meet OS End Point in Advanced Gastric Cancer
27 Jan 2025 19:24 GMT
… either pembrolizumab, lenvatinib, and chemotherapy or chemotherapy alone. During the induction … 5-fluorouracil (5-FU) plus 2400 mg/m2 of continuous intravenous 5-FU … standards.
“Gastric and gastroesophageal cancers continue to present challenges due …
-
Merck & Eisai provide update on phase 3 LEAP─015 trial of Keytruda plus Lenvima in combo with chemotherapy in patients with certain types of gastroesophageal adenocarcinoma
27 Jan 2025 04:40 GMT
… cancer, Keytruda is approved in combination with fluoropyrimidine- and platinum-containing chemotherapy … : bolus IV 5-fluorouracil (5-FU) 400 mg/m2, plus 5-FU 2400 mg…
-
Watch-and-Wait Strategy Shows Safety in Rectal Cancer Responder Population
25 Jan 2025 23:24 GMT
… at the 2025 ASCO Gastrointestinal Cancer Symposium.1 Furthermore, no differences … ], and oxaliplatin) for systemic chemotherapy and 5-fluorouracil (5-FU) plus oxaliplatin CRT at 50 …
-
Pembrolizumab Plus Lenvatinib and Chemo Misses OS End Point in Gastroesophageal Adenocarcinoma
24 Jan 2025 16:20 GMT
… a leading cause of cancer death worldwide,” Gregory Lubiniecki … plus lenvatinib with chemotherapy vs chemotherapy alone in the … at the 2023 Gastrointestinal Cancers Symposium,2 and the … 5-fluorouracil (5-FU) at 400 mg/m2, plus continuous IV 5-FU …
-
Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma
24 Jan 2025 12:04 GMT
… : bolus IV 5-fluorouracil (5-FU) 400 mg/m2, plus 5-FU 2400 mg… approved test.
Cervical Cancer
KEYTRUDA, in combination with chemoradiotherapy (CRT), is indicated … triple-negative breast cancer (TNBC) in combination with chemotherapy as neoadjuvant …
About
© 1995-2025